Vedic Lifesciences Holds Investigator Meet for Sexual Health Studies
The company held the meetings to encourage open discussion on study protocols.
Vedic Lifesciences (Redwood Shores, CA) announced today that it recently held investigator meetings for two upcoming product studies on sexual dysfunction in men and women.
The meetings were held on November 28 and December 5 for the company’s Phase II Female Sexual Dysfunction study and Phase II Male Sexual Dysfunction study.
Both studies will be performed in India (where the company has its world headquarters) in multicenter, open-label, and placebo-controlled fashion.
Jayesh Chaudhary, the company’s managing director, urged for the clinical investigator meetings as opportunities to provide information on study protocol and Good Clinical Practice (GCP) training.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
